Aberrant JAK-STAT signaling may result from the activation of a mutation in the IL7R pathway, which frequently occurs in the TLX, HOXA, and ETP T-ALL subgroups [92,93,94] (Figure 2). This evidence concerns the gene IL7R and acute lymphoblastic leukemia.